Voyager Therapeutics News and Activities

Presence

Voyager Therapeutics develops gene medicines for brain and nervous system diseases. Its products and services include gene therapy platforms, drug discovery, and research partnerships for patients, healthcare providers, and biopharmaceutical companies.

Voyager Therapeutics products and services overview:

Gene therapies
Drug discovery
Research partnerships
RNA medicines
Delivery platforms

Revenue: ~$100 million

Employees: 180

Headquarters: Lexington, United States (USA)

Voyager Therapeutics is one of the...

Voyager Therapeutics is a company listed under the stock ticker VYGR (US).

Executives

View the org chart displaying its 16 main executives

Most searched biographies at Voyager Therapeutics

Popular executive movements at Voyager Therapeutics

Toby Ferguson, Chief Medical Officer, has left the company (posted on April 23 2026).
Robin Swartz who is Chief Business Officer and Chief Operating Officer, will become Chief Business Officer, Chief Operating Officer and Principal Financial Officer and Treasurer on May 8, 2026 (posted on April 22 2026).
Amy Quinlan who was Vice President of Finance, becomes Principal Accounting Officer (posted on April 22 2026).

Click here to view some more movements at Voyager Therapeutics

Create your alert
to follow the executive moves at Voyager Therapeutics.